Europa Worldwide Group Enhances Carbon Management and Reporting With Blue Yonder
Leading British LSP adopts accredited, precise emissions reporting to meet growing customer demand for more environmentally responsible operations LONDON & DALLAS–(BUSINESS... Read more.
8×8 and Southampton FC Renew Partnership to Bridge Gap Between Telephone and Terrace
LONDON–(BUSINESS WIRE)–8×8, Inc. (NASDAQ: EGHT), the industry’s most integrated customer experience (CX) platform provider, today announced the... Read more.
Hunting PLC (“Hunting” or “the Company” or “the Group”) Launch of Share Buyback Programme of up to $40 million
Return of capital reflects strategic progress and confidence in future prospects LONDON–(BUSINESS WIRE)–Hunting PLC (LSE:HTG), the precision engineering... Read more.
QIAGEN N.V. Launches Non-US Offering of Net Share Settled Convertible Bonds
VENLO, Netherlands–(BUSINESS WIRE)–$QGEN #QIAGEN—NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA,... Read more.
Syngenta Group Reports H1 2025 Earnings
H1 2025 Group sales at $14.5 billion, flat versus prior year (+2% at CER) Q2 Group sales at $7.2 billion Strong H1 2025 EBITDA growth at $2.5 billion, +24% (+29%... Read more.
PureTech Health plc – Half-Year Report
Achieved meaningful progress toward key value inflection points across our diversified portfolio, with multiple programs advancing into or toward late-stage development... Read more.
Regula Recognized by Gartner in Magic Quadrant for Identity Verification
RESTON, Va.–(BUSINESS WIRE)–#gartner—Regula, a global developer of identity verification (IDV) solutions and forensic devices, has been recognized... Read more.
Hunting PLC (“Hunting” or “the Company” or “the Group”) Results for the Six Months Ended 30 June 2025
Strong financial performance, reporting year-on-year growth in revenue, adjusted operating profit and adjusted earnings, in line with management’s expectations... Read more.
Cool Company Ltd. Q2 2025 Business Update
LONDON–(BUSINESS WIRE)–This release includes business updates and unaudited interim financial results for the three months (“Q2”, “Q2... Read more.
CEL-SCI Announces Pricing of $10 Million Public Offering
VIENNA, Va.–(BUSINESS WIRE)–CEL-SCI Corporation (“CEL-SCI” or the “Company”) (NYSE American: CVM), a clinical stage cancer immunotherapy company,... Read more.